Modulim
PrivateLast Round
Grant
May 18, 2023
Total Funding Raised
$16.11M
Company Overview
Modulim is a medical device company that develops and commercializes non-invasive optical imaging platforms powered by spatial frequency domain imaging (SFDI) to assess microvascular tissue health for the prevention and management of chronic wound complications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Healthcare Analytics, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulim Comparables
Compare Modulim with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MIMOSA Diagnostics | 84% | |
| VOTIS Subdermal Imaging Technologies | 82% | |
| Kent Imaging | 82% |
Modulim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 18, 2023 | ||||
| Series C | Dec 8, 2020 | ||||
| Debt | Apr 27, 2020 | ||||
| Series B | Jan 23, 2019 | ||||
| Grant | Nov 17, 2017 | ||||
Series A | Nov 17, 2017 |
Modulim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| Grey Sky Venture Partners | Series B, Series A |
| NIH RADx | Grant |
| Cove Fund | Seed |
| Fresenius Medical Care Ventures | Series A, Series B |
| Mitsubishi UFJ Capital | Series A, Series B |
| Pangaea Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2023
$3M grant from the United States Army Medical Materiel Development Activity.
- Dec 8, 2020
Raised Series C round
Modulim Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Modulim's valuation, stock price, and market status.
Is Modulim a public or private company?
Modulim is a private company.
What is the current stock price of Modulim?
Modulim is a private company with no public stock price. No recent secondary market data is available.
How much is Modulim worth (valuation)?
Valuation information for Modulim is not publicly available.
Can I buy Modulim stock?
Modulim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Modulim's last funding round?
Modulim's most recent funding round was Grant on May 18, 2023.
Who are the main investors in Modulim?
Key investors in Modulim include National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grey Sky Venture Partners, NIH RADx, Pangaea Ventures.
Will Modulim IPO soon?
No public IPO plans have been announced for Modulim.
How can I track Modulim secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Modulim's secondary market activity and sign up for updates.